Some top-selling diabetes drugs in India may not be safe for patients, says a team of international experts, according to whom, the country’s drug regulatory system allows use of a treatment that has not been found effective or safe. For their study, published in the British Medical Journal, the researchers used World Health Organisation (WHO) guidelines for approving metformin fixed-dose combinations (FDC) to assess the efficacy and safety of those top-selling diabetes drugs in India. “This work is relevant to an active case in the courts in India. We are…
Read MoreSome top-selling diabetes drugs in India not safe: Experts
